To test whether this effect was PPAR-dependent, we measured proliferation of the haploid human leukemia cell line HAP1, and genetically engineered versions that lack functional proteins PPARα (HAP1 PPARA KO) or PPARγ (HAP1 PPARG KO), after adding arachidonic acid. Here, PPARG is linked to leukemia.